Injecting in the abdomen: technique, the 2-inch rule and what to avoid

The abdomen is the site most people start with, and for a reason: it is easy to see, easy to reach with either hand, and it has a lot of room for rotation. Every GLP-1 label lists it first. This guide walks through one abdominal injection from fridge to sharps bin, separating what the instructions for use actually say from the general injection practice that fills the gaps.

What the labels say about the abdomen

The prescribing information for Zepbound, Mounjaro, Wegovy and Ozempic all say the same three things: inject subcutaneously in the abdomen, thigh or upper arm; rotate injection sites with each dose; do not inject into a muscle or a vein. Ozempic's label adds that you may use the same body region each week, but the injections should not be adjacent to each other.

The patient-facing instructions for use add detail the prescribing information leaves out. Wegovy's say to inject into the lower stomach and keep 2 inches away from the belly button, not to inject where the skin is tender, bruised, red or hard, and to avoid scars and stretch marks. Zepbound's say the same 2-inch rule for the stomach, and that you may use the same area of the body as long as you choose a different site within it.

That is the entire label content on abdominal technique. Everything below that goes further is general subcutaneous injection practice, mostly from the Forum for Injection Technique recommendations (Frid 2016, PubMed 27594187), which were written for insulin and are the most detailed published guidance on rotation and skin care for weekly injectables too.

The usable area

Picture a band across the front of the abdomen, from a hand's width below the ribs to the top of the pubic bone, and from one flank to the other. Now remove a circle 2 inches in radius around the navel. What is left, on each side, is your abdominal injection field. Most adults can fit eight or more distinct spots per side with a thumb's width between them.

Two things shrink that field. The first is skin that should be skipped on the day: anything tender, bruised, red, hard, scarred or stretch-marked, per the Wegovy instructions. Bruising from last week's injection counts. The second is lipohypertrophy, the firm, rubbery thickening that develops when the same spot is injected repeatedly. FIT describes it as the most common local complication of repeated subcutaneous injection and as a cause of erratic drug absorption. It is why rotation is on the label, and why the rotation planner never puts two injections on the same spot in a row.

Step by step

Take the pen or vial out of the fridge. Wegovy and Zepbound pens can be injected cold; there is no label requirement to warm them. Some people find a cold injection stings more and leave the pen out for 15 to 30 minutes, which is within the room-temperature allowance on every label (see the storage guide). Do not warm a pen in hot water or a microwave; the labels say to protect the drug from heat.

Check the pen. Look through the window: the solution should be clear and colourless to slightly yellow (Zepbound) or clear and colourless (Wegovy). If it is cloudy, coloured or has particles, the instructions for use say not to use it. Check the expiry date and, for a multi-dose pen, the date you first used it.

Wash your hands. Choose the spot from your rotation plan, then look at it and touch it. If it fails the skin check, move to the next spot on the plan, on the same side.

Clean the skin if you have been taught to. Neither the Wegovy nor the Zepbound instructions for use require an alcohol swab, and FIT notes that disinfection is generally not needed for injections at home with clean skin. If you do swab, let the alcohol dry completely first; injecting through wet alcohol is what stings.

Prepare the pen. For a Wegovy single-dose pen, pull off the cap and check the window. For a Zepbound single-dose pen, unlock it after placing it on the skin. For a Zepbound KwikPen or an Ozempic pen, attach a new needle, then prime: Zepbound's KwikPen instructions say to prime before every weekly injection; Ozempic's say to do the flow check with each new pen only. The pen versus vial guide walks through each device.

Inject. The Wegovy and Zepbound auto-injector pens are pressed flat against the skin at a right angle and held until the injection completes. Wegovy's instructions say to hold until the yellow bar has stopped moving; Zepbound's say to hold up to 10 seconds and listen for two clicks, the first when the injection starts and the second when it is done, then check that the grey plunger is visible. With a vial and syringe, the Zepbound vial instructions say to inject exactly as your healthcare provider showed you and that your provider should tell you whether to pinch the skin. FIT's general recommendation for short needles is a 90-degree insertion without a pinch in most adults, with a pinch reserved for very lean areas.

Withdraw, then press. A cotton ball or gauze pressed on the site for a few seconds limits bruising. Do not rub; rubbing spreads the depot and can bruise.

Dispose. The used pen or needle goes into an FDA-cleared sharps container, or a heavy-duty plastic household container with a screw lid, per FDA's sharps disposal guidance. Never into the recycling, and never loose in the trash.

Record it. Site, date, side, spot. The planner prints a column for a tick; a dose log does the rest.

Common problems on the abdomen

A drop of liquid on the skin after withdrawal. Usually a trace on the needle tip, not a lost dose. If a visible bead runs down the skin after a pen injection, do not inject a second time; the labels' missed-dose rules do not cover partial doses and a repeat risks a double dose. Note it and mention it to your prescriber. Holding the pen in place for the full count is the main prevention.

Bruising. Common, harmless, and more likely with blood thinners, with rubbing, or with a spot that was already bruised. It is a reason to rotate further away next week, not a reason to stop. Bleeding that does not stop with pressure, or a bruise that spreads and hardens, warrants a call.

Redness or a raised itchy patch. The Zepbound label reports injection site reactions in 6 to 8 percent of people on 5 to 15 mg versus 2 percent on placebo, pooled from the SURMOUNT-1 and SURMOUNT-2 trials. Most are mild and short-lived. Hives beyond the site, swelling of the face or throat, or trouble breathing are a different matter: the labels list hypersensitivity reactions including anaphylaxis and angioedema as reasons to stop and seek medical attention.

A hard lump that persists. If it is at a spot you have used more than once, suspect lipohypertrophy and retire that spot for several months, which is FIT's advice. If it is warm, painful and growing, or you have a fever, it needs a clinician; that is an infection until proven otherwise.

"I hit muscle." With a 4 to 6 mm pen needle at 90 degrees into the abdomen of most adults, reaching muscle is unlikely; FIT reviewed the skin and subcutaneous thickness data behind that. If you are very lean around the injection site, use a pinch for a syringe injection, or discuss the thigh with your prescriber.

Abdomen versus the other sites

The labels treat the three sites as equivalent and give no site-specific absorption data for semaglutide or tirzepatide in the clinical pharmacology sections. Novo Nordisk's Ozempic label states that exposure was similar across abdomen, thigh and upper arm. So the choice is practical: reach, comfort, room to rotate. Many people alternate the abdomen with the thigh week to week, which the planner's "change region every week" pattern lays out.

Compounded vials

If your medication is a compounded semaglutide or tirzepatide vial rather than a brand pen, none of the device steps above apply and the concentration on your vial decides the volume you draw. Compounded products are not FDA approved and are not interchangeable with the brand products whose labels this guide cites. Follow your pharmacy's instructions, run the arithmetic through the dose unit converter, and read FormBlends' own product pages for semaglutide and tirzepatide for what its pharmacies dispense. The site selection, skin check, 2-inch rule and rotation still apply exactly as above.